Literature DB >> 23109746

Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.

Luis Meave Gutiérrez-Mendoza1, Brian Schwartz, José de Jesús Méndez de Lira, Veronika J Wirtz.   

Abstract

PROBLEM: During an influenza outbreak or pandemic, timely access to antivirals is essential to reduce disease severity and transmission. Best practices in antiviral procurement, storage, distribution, prescription and dispensing must be followed for prompt drug delivery. APPROACH: Mexico implemented a national pandemic preparedness plan in 2006 and created a strategic antiviral stockpile. Oseltamivir powder was stored centrally in bulk for distribution to all 31 states and the capital district during an influenza outbreak. LOCAL
SETTING: San Luis Potosí, in northern Mexico, was one of the states most intensely affected by the 2009 H1N1 influenza outbreak. RELEVANT CHANGES: The oseltamivir powder was meant to be reconstituted locally but had to be reconstituted centrally during the 2009 influenza outbreak. Doubts arose surrounding the shelf-life of the reconstituted product. As a result of these problems, the first supply of the drug reached San Luis Potosí 11 days after the influenza outbreak had begun. Furthermore, dispensing criteria at the state level had to be changed in conformity with the availability of oseltamivir. LESSONS LEARNT: Antiviral demand forecasts should be based on clearly defined distribution and dispensing criteria and decentralization of some of the medication stockpile should be considered. Mexico's national pandemic preparedness plan needs to be updated in accordance with the lessons learnt in 2009 to improve strategic stockpile management and ensure rapid delivery of oseltamivir to the population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109746      PMCID: PMC3471052          DOI: 10.2471/BLT.11.101733

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective.

Authors:  Luis R Carrasco; Vernon J Lee; Mark I Chen; David B Matchar; James P Thompson; Alex R Cook
Journal:  J R Soc Interface       Date:  2011-02-04       Impact factor: 4.118

2.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico.

Authors:  Alejandro Gómez-Gómez; Martin Magaña-Aquino; Christian Garcia-Sepúlveda; Uciel R Ochoa-Pérez; Reynaldo Falcón-Escobedo; Andreu Comas-García; Saray Aranda-Romo; Hugo I Contreras-Treviño; Paulina V Jimenéz-Rico; Mario A Banda-Barbosa; Félix Dominguez-Paulin; J Mario Bernal-Blanco; Luis F Peréz-González; Daniel E Noyola
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

4.  Cost-benefit of stockpiling drugs for influenza pandemic.

Authors:  Ran D Balicer; Michael Huerta; Nadav Davidovitch; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

Review 5.  Major issues and challenges of influenza pandemic preparedness in developing countries.

Authors:  Hitoshi Oshitani; Taro Kamigaki; Akira Suzuki
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

  5 in total
  4 in total

1.  The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective.

Authors:  Angela Holly Villamagna; Sara J Gore; James S Lewis; J Stone Doggett
Journal:  Front Med (Lausanne)       Date:  2020-12-22

2.  Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.

Authors:  Aeron C Hurt; Heath Kelly
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

3.  Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?

Authors:  César Parra-Rojas; Van Kinh Nguyen; Gustavo Hernandez-Mejia; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2018-08-25       Impact factor: 5.048

4.  Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases.

Authors:  Mario Bermúdez de León; Rafael B R León-Cachón; Beatriz Silva-Ramírez; Rosa Nelly González-Ríos; Brenda Escobedo-Guajardo; Roberto Leyva-Parra; Benjamín Tovar-Cisneros; Everardo González-González; Abdiel Alvarado-Díaz; Ofelia Vázquez-Monsiváis; Viviana Mata-Tijerina; Lorena Puente-Lugo; Erick Álvarez-Galván; María José Currás-Tuala; Miguel Aguado-Barrera; Fabiola Castorena-Torres; Juan Manuel Alcocer-González; Guillermo Elizondo; Ana María Salinas-Martínez
Journal:  Pharmacogenomics J       Date:  2020-02-04       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.